- Report
- October 2025
- 150 Pages
Global
From €4320EUR$4,850USD£3,714GBP
- Report
- February 2026
- 196 Pages
Global
From €4320EUR$4,850USD£3,714GBP
- Report
- July 2026
- 130 Pages
Global
From €4320EUR$4,850USD£3,714GBP
- Report
- January 2026
- 172 Pages
Global
From €4409EUR$4,950USD£3,790GBP
- Report
- June 2026
- 200 Pages
Europe
From €2663EUR$2,990USD£2,289GBP
- Report
- September 2025
- 90 Pages
Middle East
From €4409EUR$4,950USD£3,790GBP
- Report
- July 2026
- 100 Pages
United States
From €4231EUR$4,750USD£3,637GBP
- Report
- May 2026
- 150 Pages
United States
From €4320EUR$4,850USD£3,714GBP
- Report
- February 2026
- 263 Pages
North America
From €5340EUR$5,995USD£4,590GBP
- Report
- February 2026
- 256 Pages
Europe
From €5340EUR$5,995USD£4,590GBP
- Report
- February 2026
- 244 Pages
Asia Pacific
From €5340EUR$5,995USD£4,590GBP
- Report
- January 2026
- 72 Pages
Africa, Middle East
From €3073EUR$3,450USD£2,642GBP
- Report
- January 2026
- 85 Pages
Asia Pacific
From €3518EUR$3,950USD£3,025GBP
- Report
- January 2026
- 87 Pages
Europe
From €3518EUR$3,950USD£3,025GBP
- Report
- January 2026
- 80 Pages
North America
From €3073EUR$3,450USD£2,642GBP
- Report
- December 2022
- 354 Pages
Global
From €4756EUR$5,526USD£3,950GBP
- Report
- October 2018
- 450 Pages
Global
From €3117EUR$3,499USD£2,679GBP
- Report
- March 2023
- 450 Pages
Global
From €4756EUR$5,526USD£3,950GBP
- Report
- July 2022
- 159 Pages
Global
From €2093EUR$2,350USD£1,799GBP
- Report
- July 2025
- 475 Pages
Global
From €4409EUR$4,950USD£3,790GBP

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more